A tunable dual-promoter integrator for targeting of cancer cells.
about
Tunable and multifunctional eukaryotic transcription factors based on CRISPR/CasRecent advances and opportunities in synthetic logic gates engineering in living cellsSynthetic therapeutic gene circuits in mammalian cellsSynthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseasesSynthetic biology in mammalian cells: next generation research tools and therapeuticsRecent advances and versatility of MAGE towards industrial applicationsThe biological microprocessor, or how to build a computer with biological partsDigital and analog gene circuits for biotechnology.Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells.Antagonistic control of a dual-input mammalian gene switch by food additives.A designer cell-based histamine-specific human allergy profiler.A synthetic biology framework for programming eukaryotic transcription functions.Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant.A library of programmable DNAzymes that operate in a cellular environment.A general design strategy for protein-responsive riboswitches in mammalian cells.Cosmetics-triggered percutaneous remote control of transgene expression in mice.Spatiotemporal dynamics of distributed synthetic genetic circuitsSynthetic dual-input mammalian genetic circuits enable tunable and stringent transcription control by chemical and light.Cellular heterogeneity mediates inherent sensitivity-specificity tradeoff in cancer targeting by synthetic circuits.Two- and three-input TALE-based AND logic computation in embryonic stem cells.Synthetic mammalian gene networks as a blueprint for the design of interactive biohybrid materials.Emerging biomedical applications of synthetic biology.Molecular switches in animal cells.Biomedically relevant circuit-design strategies in mammalian synthetic biology.Integration of microfluidics into the synthetic biology design flow.Mammalian synthetic biology: emerging medical applications.Mammalian designer cells: Engineering principles and biomedical applications.Synthetic biology: applying biological circuits beyond novel therapies.Synthetic Biology-The Synthesis of Biology.Engineering Gene Circuits for Mammalian Cell-Based Applications.Engineering of synthetic gene circuits for (re-)balancing physiological processes in chronic diseases.Engineering modular and orthogonal genetic logic gates for robust digital-like synthetic biology.Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells.A bistable genetic switch based on designable DNA-binding domains.Synthesizing oncogenic signal-processing systems that function as both "signal counters" and "signal blockers" in cancer cells.A tunable zinc finger-based framework for Boolean logic computation in mammalian cellsA modular cell-based biosensor using engineered genetic logic circuits to detect and integrate multiple environmental signals.A programmable NOR-based device for transcription profile analysis.Designed cell consortia as fragrance-programmable analog-to-digital converters.
P2860
Q24606465-80CF8E16-C017-43B5-9827-63DC88D69904Q26781904-025EADD8-F17A-49DD-9CFB-C96AC106ED05Q26826954-DC25D8B0-C47C-470C-804A-0075B51C60B6Q26830610-C173131C-4BC1-43A7-91B1-98F309CD6472Q26995293-2C6906B0-A3F7-4B25-A1C6-723612437938Q28081937-759B80C9-4FE2-4262-8EB2-10CBAE0DE5C2Q28660797-1DD39212-47BC-4C02-BE69-25DC7FC32CEFQ33828854-A79D5CDC-DE2A-4109-B414-AD93CE59D251Q33830378-BCB0F1C3-DD2A-4DB7-9BAB-2F37FEF9C2DAQ34044270-1AFB3B4F-D4DC-449D-B087-FE8459F12B72Q34086352-527C0718-999D-4F77-81B1-6ED2D9BB18BCQ34292208-0FB74D20-AA19-47C6-A293-95C114471C6CQ34533542-49772C41-F01E-4D00-9FDB-EB5BC959DFDDQ34563731-39B4C6EA-51FA-4ED5-9822-ECE95496ED99Q34633523-FFE09435-ABE1-4B6E-ADFC-0D037CAC33E1Q35302203-8CBF5664-4DB8-42D2-BECB-63490355411BQ35961864-18B54533-9A17-4CD7-8B16-8210FD5DE2FDQ36651612-41FFE2FB-861B-4F0F-92C0-2231CB5258F5Q36775481-DCA80E9C-E34A-4CCB-B0DF-783B8F07484CQ37126699-25F44811-28AA-4C8B-B2CE-90D4231D56DDQ37327607-4BACF624-68E3-4CA4-BF91-7E70AF166147Q37926924-C814A30D-6B74-4E56-8BB9-7A993C321708Q37962354-9C844474-8C27-4C6F-B7AF-2C66C46C0DD9Q38019715-0B0B0024-D0CD-43CB-B44C-F0ED219C12CEQ38141796-58CF9858-F730-43C9-8AFD-61C8FB7F7514Q38228150-B1E6F1A0-95BF-4169-8C9A-15CFD0027E7CQ38390803-805A94BE-5870-46D3-8D0B-8CE1AC8521ACQ38502748-38489589-C912-4D0E-A267-6B373150E200Q38679815-B38D6944-085D-48C3-92C2-5E87715F26D0Q38784006-11D414BA-CF3E-41C4-8762-7523981B2B29Q38837855-74A0E0D4-45D0-4344-9D36-538ACC504E93Q38876131-DD506B2D-60AB-4032-A3E0-E22B829A0377Q38924442-3F5D5787-233C-4C3B-9FEF-8EC9EC0B8238Q38942406-B657B2E7-8E5F-42F2-8734-5870C70D8757Q38952478-B4864B63-C422-49DD-B23D-DD41D65E582BQ39160249-12B1C352-2CE0-4423-96EC-BBA639972C2EQ39398363-AD228DB8-E77F-4B09-9683-7CBE96784288Q39552299-4DECB38D-4132-4D86-9EE3-D14FAF065FFEQ39555731-02B1D2A2-FD46-4B06-A508-59FDC6AEF0F9Q40435718-4D361B98-0E1C-4D1F-8DB1-E4257B4D57A0
P2860
A tunable dual-promoter integrator for targeting of cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A tunable dual-promoter integrator for targeting of cancer cells.
@en
A tunable dual-promoter integrator for targeting of cancer cells.
@nl
type
label
A tunable dual-promoter integrator for targeting of cancer cells.
@en
A tunable dual-promoter integrator for targeting of cancer cells.
@nl
prefLabel
A tunable dual-promoter integrator for targeting of cancer cells.
@en
A tunable dual-promoter integrator for targeting of cancer cells.
@nl
P2860
P356
P1476
A tunable dual-promoter integrator for targeting of cancer cells.
@en
P2093
Lior Nissim
Roy H Bar-Ziv
P2860
P356
10.1038/MSB.2010.99
P577
2010-12-01T00:00:00Z